Settlement with Dr. Reddy's Laboratories shields key drugs NEXLETOL and NEXLIZET from generic competition until 2040, boosting investor confidence.
A notorious ransomware group claims to have stolen sensitive corporate data, putting Oracle's reputation and customer security under scrutiny.
Governor Newsom's signature on AB30 is expected to expand the ethanol market by over 600 million gallons annually.
The networking specialist saw trading volume spike more than 50 times its daily average following the announcement.
Sale was executed under a pre-planned 10b5-1 trading arrangement as the AI chipmaker's valuation continues to soar.
The industrial laser firm's strategic pivot into the electronic warfare and operational resilience markets is fueled by a new capital raise and key acquisitions.
The $0.3 million deal with a major Southern European telecom carrier boosts the network solutions provider's shares in after-hours trading.
Company transfers equity stake in a strategic deal for future capital rights, resolving outstanding brand disputes and boosting investor confidence.